Meaningful reform was challenging in 2024, but this year could turn the tide.
Additional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.
Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.
Closing out their discussion on marginal zone lymphoma, the panel considers which future treatment strategies are most promising.
Beyond the benefits to the pharmacist profession, granting provider status to pharmacists addresses the larger societal problem of growing physician shortages.
Specialty pharmacy experts discuss how emotional support, addressing patient loneliness, and peer-to-patient programs can significantly improve medication adherence and patient care.
A projected shortage of trained staff in the years ahead demands looking beyond normal hiring channels.
Discussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.
Experts in gynecologic oncology provide insight on available patient assistance programs to help lower costs of PARP inhibitors for the treatment of ovarian cancer, and how pharmacists can aid in obtaining this information.
Although approximately 95% of online drug sellers operate illegally, many consumers may never know the medications they receive are not what they claim to be.
As use of injectable medications increases for diabetes and other indications, proper administration is crucial.
Vincent Chung, MD, discusses key findings from the NAPOLI-3 trial and offers guidance for pharmacists on managing toxicities, adjusting dosing, and supporting patients receiving NALIRIFOX for metastatic pancreatic ductal adenocarcinoma.
There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.
Lack of acknowledgement or rewards in high-pressure pharmacy environments can lead to mental health issues.
Panelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.
Implementation of a guidance document for periprocedural antibiotic prophylaxis resulted in improved appropriateness of antibiotic dose, selection, and duration for interventional radiology procedures.
To eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.
Pharmacists can play a key role in providing education and guidance to patients with glaucoma.
The measures will also affect workers across all areas of the hospital, including dietitians, information technology, nurses, and physicians.
Ketamine topical cream may alleviate symptoms of PTSD without causing the adverse effects and abuse potential often associated with other forms of ketamine administration.
Pharmacists are well-positioned to address diabetes from a multifaceted approach.
Motivational interviewing serves as a beneficial strategy to enhance medication adherence and improve patient outcomes in diabetes management.
Finding the right medication or drug combination for individual patients is critical.
Improved prescription information could help consumers make better health care decisions and result in cost savings.
Legal issues surfaced once again with the COVID-19 pandemic
Although the anticonvulsant is not considered a controlled substance, some state legislation focuses on monitoring the use of or reclassifying it.
Protecting this vulnerable patient population requires specially designed strategies.
Past proposal gives insight into lawmakers' thinking about medicinal use of cannabis on a federal level.